Literature DB >> 11301049

Regulation of TNFalpha and interleukin-10 production by prostaglandins I(2) and E(2): studies with prostaglandin receptor-deficient mice and prostaglandin E-receptor subtype-selective synthetic agonists.

S Shinomiya1, H Naraba, A Ueno, I Utsunomiya, T Maruyama, S Ohuchida, F Ushikubi, K Yuki, S Narumiya, Y Sugimoto, A Ichikawa, S Oh-ishi.   

Abstract

To know which receptors of prostaglandins are involved in the regulation of TNFalpha and interleukin 10 (IL-10) production, we examined the production of these cytokines in murine peritoneal macrophages stimulated with zymosan. The presence of PGE(2) or the PGI(2) analog carbacyclin in the medium reduced the TNFalpha production to one-half, whereas IL-10 production increased several fold; and indomethacin caused the reverse effects, suggesting that endogenous prostaglandins may have a regulatory effect on the cytokine production. Among prostaglandin E (EP) receptor-selective synthetic agonists, EP2 and EP4 agonists caused down-regulation of the zymosan-induced TNFalpha production, but up-regulation on the IL-10 production; while EP1 and EP3 agonists showed no effect. Macrophages harvested from prostaglandin I (IP) receptor-deficient mice showed the up- and down-regulatory effects on the cytokine production by the EP2 and EP4 agonists or PGE(2), but no effect was obtained by carbacyclin. On the contrary, macrophages from EP2-deficient mice showed the effect by PGE(2), carbacyclin, and the EP4 agonist, but not by the EP2 agonist; and the cells from EP4-deficient mice showed the effect by PGE(2), carbacyclin, and EP2 agonist, but not by the EP4 agonist. These functional effects of prostaglandins well accorded with the mRNA expression of TNFalpha and IL-10 when such expression was examined by the RT-PCR method. The peritoneal macrophages from normal mice expressed IP, EP2, and EP4 receptors, but not EP1 and EP3, when examined by RT-PCR. Thus the results suggest that PGI(2) and PGE(2) generated simultaneously with cytokines by macrophages treated with zymosan may influence the cytokine production through IP, EP2, and EP4 receptors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11301049     DOI: 10.1016/s0006-2952(01)00586-x

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  44 in total

Review 1.  Genetic and pharmacological analysis of prostanoid receptor function.

Authors:  S Narumiya; G A FitzGerald
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

Review 2.  Stem cells in sepsis and acute lung injury.

Authors:  Sushma K Cribbs; Greg S Martin
Journal:  Am J Med Sci       Date:  2011-04       Impact factor: 2.378

3.  Skin-Derived Mesenchymal Stem Cells Alleviate Atherosclerosis via Modulating Macrophage Function.

Authors:  Qun Li; Weihong Sun; Xinwen Wang; Ke Zhang; Wenda Xi; Pingjin Gao
Journal:  Stem Cells Transl Med       Date:  2015-09-23       Impact factor: 6.940

4.  Increased lethality and defective pulmonary clearance of Streptococcus pneumoniae in microsomal prostaglandin E synthase-1-knockout mice.

Authors:  Jennifer M Dolan; Jason B Weinberg; Edmund O'Brien; Anya Abashian; Megan C Procario; David M Aronoff; Leslie J Crofford; Marc Peters-Golden; Lindsay Ward; Peter Mancuso
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-04-08       Impact factor: 5.464

Review 5.  Tumor necrosis factor-alpha and the roles it plays in homeostatic and degenerative processes within the central nervous system.

Authors:  Sara L Montgomery; William J Bowers
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-05       Impact factor: 4.147

Review 6.  A lipidomic perspective on inflammatory macrophage eicosanoid signaling.

Authors:  Paul C Norris; Edward A Dennis
Journal:  Adv Biol Regul       Date:  2013-09-25

Review 7.  Prostaglandin E2 as a Regulator of Immunity to Pathogens.

Authors:  Giovanny J Martínez-Colón; Bethany B Moore
Journal:  Pharmacol Ther       Date:  2017-12-22       Impact factor: 12.310

Review 8.  COX-2 inhibitors as adjunctive therapy in schizophrenia: rationale for use and evidence to date.

Authors:  Michael Riedel; Martin Strassnig; Markus J Schwarz; Norbert Müller
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 9.  Production of eicosanoids and other oxylipins by pathogenic eukaryotic microbes.

Authors:  Mairi C Noverr; John R Erb-Downward; Gary B Huffnagle
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

10.  Prostaglandin E receptor type 4-associated protein interacts directly with NF-kappaB1 and attenuates macrophage activation.

Authors:  Manabu Minami; Koichi Shimizu; Yoshihisa Okamoto; Eduardo Folco; Marco-Lopez Ilasaca; Mark W Feinberg; Masanori Aikawa; Peter Libby
Journal:  J Biol Chem       Date:  2008-02-12       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.